14 July 2017 - Deborah Wilkes
Archived
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is consulting on a proposal to switch Arthriex tablets containing glucosamine sulfate from prescription to non-prescription status for relieving osteoarthritis of the knee.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.